Expertise in
46
conditions

Dr. Ryan S. Raddin

Hematology | Oncology
14051 St Francis Boulevard, Suite 2210, 
Midlothian, VA 
Accepting New Patients
Offers Telehealth
Expertise in
46
conditions
14051 St Francis Boulevard, Suite 2210, 
Midlothian, VA 

Overview

I am grateful to be practicing Oncology and Hematology in my hometown of Midlothian, where I’ve had the privilege of building relationships with my patients and their families over the years. I enjoy the challenge of diagnosing complex medical conditions and using innovative technology to find the most effective treatment options for patients. Outside of work, you’ll find me spending time with my wife, two young sons, and our dog Samwise.

Dr. Raddin is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).

Dr. Raddin is board certified in (Internal Medicine, Medical Oncology), (Internal Medicine, Hematology), and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 4 peer reviewed articles. Dr. Raddin is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in NC

Board Certifications

(Internal Medicine, Medical Oncology)
(Internal Medicine, Hematology)
American Board Of Internal Medicine

Fellowships

University Of North Carolina School Of Medicine, Hematology & Oncology - 2012

Hospital Affiliations

Bon Secours St. Francis Medical Center
Bon Secours Richmond Community Hospital
Bon Secours Memorial Regional Medical Center
Bon Secours - St. Mary's Hospital
Bon Secours St Francis Medical Center
Bon Secours Richmond Community Hospital
Bon Secours Memorial Regional Medical Center
Bon Secours St Marys Hospital
Bon Secours Southside Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Bon Secours Cancer Institute at St. Francis
14051 St Francis Boulevard, Suite 2210, Midlothian, VA 23114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Total Publications

A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
Journal: Clinical lung cancer
Published: July 13, 2020
Similar Doctors
Expertise in
21
conditions
Dr. Benjamin W. Purow
Hematology | Oncology
Expertise in
21
conditions
Dr. Benjamin W. Purow
Hematology | Oncology
Referral may be required

UVA Health Neuro Oncology

1240 Lee St Fl 3, 
Charlottesville, VA 
 (58.5 miles away)
434-924-9333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Benjamin Purow is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Purow is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Purow is currently accepting new patients.

Expertise in
30
conditions
Dr. Sosipatros A. Boikos
Hematology | Oncology
Expertise in
30
conditions
Dr. Sosipatros A. Boikos
Hematology | Oncology
Referral may be required

Virginia Commonwealth University Health System Authority

1250 E Marshall St, 
Richmond, VA 
 (13.2 miles away)
804-828-7999
Languages Spoken:
English, Greek
See accepted insurances
Accepting New Patients

Sosipatros Boikos is a Hematologist and an Oncologist practicing medicine in Richmond, Virginia. Dr. Boikos is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Neuroendocrine Tumor, and Bone Marrow Aspiration. Dr. Boikos is currently accepting new patients.

Expertise in
18
conditions
Dr. Beata H. Holkova
Hematology | Oncology
Expertise in
18
conditions
Dr. Beata H. Holkova
Hematology | Oncology
Referral may be required

Virginia Commonwealth University Health System Authority

1300 E Marshall St, 
Richmond, VA 
 (13.2 miles away)
804-828-7999
Languages Spoken:
English
See accepted insurances

Beata Holkova is a Hematologist and an Oncologist practicing medicine in Richmond, Virginia. Dr. Holkova is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), Hereditary Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Ryan S. Raddin

How do I make an appointment with Dr. Ryan S. Raddin?

You can book an appointment with Dr. Ryan S. Raddin by calling their office at 804-893-8717. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ryan S. Raddin a top-rated expert for Small Cell Lung Cancer (SCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ryan S. Raddin is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ryan S. Raddin specialize in?

While Dr. Ryan S. Raddin is a Hematology, they have specific expertise in Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Ryan S. Raddin participate in research or clinical trials?

Yes. Dr. Ryan S. Raddin has published 4 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Ryan S. Raddin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ryan S. Raddin accept my insurance?

Dr. Ryan S. Raddin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 804-893-8717 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Raddin's expertise for a condition
ConditionClose
    View All 15 Distinguished Conditions
    View All 31 Advanced Conditions
    View All 84 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile